Inverted Papilloma: An Update on Etiology, Epidemiology, and Treatment
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Bobby R. Alford Department of Otolaryngology-Head & Neck Surgery Grand Rounds session will take place on Wednesday, November 16, 2022 at 7:00 a.m. Attendance will be available in-person at the NC205 Auditorium in the Neurosensory Center of Houston; and virtually through Zoom.
Activity Information
Needs Statement
Otolaryngologists, head and neck surgeons, audiologists, speech pathologists, oral maxillofacial surgeons, residents, fellows and medical students who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of otolaryngology and head and neck surgery to increase clinical knowledge and to implement them in clinical practice to enhance the quality of patient care and outcomes.
Educational Objectives
At the conclusion of the sessions, the participants should be able to:
- Summarize the otolaryngology subspecialty topics discussed.
- Identify strategies to develop competence in the management of addressed otolaryngology topics.
- Implement changes and improvements in clinical practice patterns based on presentation of current management strategies.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Other Health Professionals
Specialties
- Otolaryngology - Head and Neck Surgery
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Activity Director
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Chris Weeks, M.D.
Otolaryngology Resident
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Activity Director
-
Krista Lee Olson, MD, FACS
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Kathleen Kelly Gallagher, MD, FACS
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Kenji Kobayashi, M.D.
Otolaryngology Resident
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Krista Lee Olson, MD, FACS
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Alex Daniel Sweeney, M.D.
Director, Hearing and Balance Center
Baylor College of Medicine
Disclosure:
- Consultancy: Cochlear LTD; MED-EL GmbH; Oticon Medical
- Advisory Committee Membership: MED-EL GmbH
- Ownership Interests (stock, stock options, excluding diversified mutual funds): GDT Innovations